Skip to main content
. 2004 Mar;57(3):310–321. doi: 10.1046/j.1365-2125.2003.02010.x

Table 2.

The participants’ scores (mean ± s.d.) regarding application of rational pharmacotherapy process, according to the physician questionnaire.ap < 0.05, intervention vs control;b p < 0.05, baseline vs long-term

Intervention Group (n = 12) Control Group (n = 13)
RUD rule Max. score Baseline Long-term Baseline Long-term
Taking patient's history into consideration in drug choice 8 4.9 ± 1.6 6.3 ± 1.2 4.9 ± 0.2.2 5.8 ± 2.1
Comparing available drug alternatives due to efficacy, safety, suitability and cost 4 1.9 ± 1.2 3.5 ± 1.0 2.6 ± 1.1 2.4 ± 1.2
Informing the patient about the disease 4 1.5 ± 0.7 1.8 ± 0.7 2.3 ± 1.0 1.9 ± 0.8
Informing the patient about the drug(s) 8 4.1 ± 1.2 5.2 ± 1.3 4.6 ± 2.5 4.3 ± 1.7
Knowing the price of the drug(s) 18 1.3 ± 1.6 4.0 ± 1.9 1.5 ± 0.6 0.5 ± 0.8